Whereas the Agency should also be responsible for coordinating the activities of the Member States in the field of the monitoring of adverse reactions to medicinal products (pharmacovigilance);
amet peaks samuti vastutama, et liikmesriikide tegevus ravimite kõrvaltoimete kontrollimisel (ravimiohutuse järelevalve) oleks kooskõlastatud;